N'GalyBMannJMHIV infection among employees in an African Hospital. N Engl J Med1988;319:1123–7.
2.
TokarsIMarcusRCulverDHCDC Cooperative Needlestick Surveillance Group. Surveillance of HIV infection and zidovudine used amongst health care workers after occupational exposure to HIV-infected blood. Ann Intern Med1993;118:913–18.
3.
HendersonDK. HIV-1 in the health care setting. In: MandelGLBennettJEDolanR, eds. Principles and Practice of Infectious Diseases, 4th edn. New York: Churchill Livingstone, 1996:2632–56.
4.
Centers for Disease Control and Prevention (CDC). Case controlled study of HIV sero-conversion in health care workers after percutaneous exposure to HIV-infected blood — France, United Kingdom and United States January 1988 to August 1994. Morb Mortal Wekly Rep1995;44:929–33.
5.
Centers for Disease Control and Prevention. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. Morb Mortal Wkly Rep1996;45:468–80.
6.
Centers for Disease Control and Prevention. Public Health Services guidelines for health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Morb Mortal Wkly Rep1998;47:1–33.
7.
CollierJ. Editorial. Drug Therapeut Bull1997;35:25–9.
8.
Glaxo-Wellcome. Information. London: Glaxo Wellcome, August 1999.
